1783 — Maxigen Biotech Share News
0.000.00%
- TWD3.50bn
- TWD2.65bn
- TWD811.56m
Brief: Maxigen Biotech to pay dividend on Aug. 24
Brief: Maxigen Biotech product Formaderm Charming Dermal Filler Injection receives TFDA approval for marketing
Brief: Maxigen Biotech announces no dividend payment for 2016
Brief: Maxigen Biotech gets marketing approval for ArtiBest Intra-articular Injection from TFDA
Brief: Maxigen Biotech gets marketing approval for Foramic Bone Graft Substitutes from CFDA
Brief: Maxigen Biotech gets CFDA marketing approval for HealiAid Collagen Wound Dressing